Merck’s Keytruda will soon lose exclusivity, just as weight-loss giants Eli Lilly and Novo Nordisk press in with their blockbuster GLP-1s.

The FDA expanded the indication of the long-acting growth hormone somapacitan (Sogroya) to include very young children with ...

In general, physicians prefer to prescribe medications that are inexpensive if they are just as good as expensive ones. There are some occasions when the newer, more expensive ones really are better.

The odor and discharge are strongly suggestive of a bacterial sinus infection. COVID infections, like all viral infections, ...

Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50 percent starting next year to $675 a month, the Danish drugmaker said Feb. 24.

The odor and discharge are strongly suggestive of a bacterial sinus infection. COVID infections, like all viral infections, ...

I am a 49-year-old woman who recently had COVID. When I was sick with it, I lost my sense of taste and smell. I no longer have COVID, but I still have a stuffy nose with no sense of taste or smell.

Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.

Cost-effectiveness is highly price-sensitive; lower U.S. prices, particularly approaching European levels, shift semaglutide toward favorable value rather than a binary go/no-go determination. Patient ...

Chronic migraine patients who used GLP-1 receptor agonists to treat conditions like obesity or diabetes had fewer emergency ...

In a move expected to benefit thousands of New Jersey residents living with obesity and type 2 diabetes, Novo Nordisk, whose U.S. headquarters is based in Plainsboro, announced it will significantly ...